These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2672262

  • 1. Laboratory survey of fluoroquinolone activity.
    Bellido F, Pechère JC.
    Rev Infect Dis; 1989; 11 Suppl 5():S917-24. PubMed ID: 2672262
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R.
    J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
    Hoban D, DeGagne P, Witwicki E.
    Diagn Microbiol Infect Dis; 1989 May; 12(3 Suppl):83S-86S. PubMed ID: 2507222
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
    Eliopoulos GM, Klimm K, Rice LB, Ferraro MJ, Moellering RC.
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1154-9. PubMed ID: 2393275
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ.
    Am J Med; 1991 Dec 30; 91(6A):19S-23S. PubMed ID: 1662890
    [Abstract] [Full Text] [Related]

  • 7. Comparative activity of the 4-quinolones.
    Phillips I, King A.
    Rev Infect Dis; 1988 Dec 30; 10 Suppl 1():S70-6. PubMed ID: 3279501
    [Abstract] [Full Text] [Related]

  • 8. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
    Fung-Tomc J, Minassian B, Kolek B, Washo T, Huczko E, Bonner D.
    J Antimicrob Chemother; 2000 Apr 30; 45(4):437-46. PubMed ID: 10747819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sparfloxacin worldwide in vitro literature: isolate data available through 1994.
    Cohen MA, Yoder SL, Talbot GH.
    Diagn Microbiol Infect Dis; 1996 Jun 30; 25(2):53-64. PubMed ID: 8882890
    [Abstract] [Full Text] [Related]

  • 13. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL, Jones RN.
    J Antimicrob Chemother; 1989 Apr 30; 23(4):527-35. PubMed ID: 2745259
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lomefloxacin: microbiologic assessment and unique properties.
    Mayer KH, Ellal JA.
    Am J Med; 1992 Apr 06; 92(4A):58S-62S. PubMed ID: 1316073
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov 06; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 20. In vitro properties of the newer quinolones.
    Nakanishi N, Kojima T, Fujimoto T, Mitsuhashi S.
    Prog Drug Res; 1992 Nov 06; 38():19-28. PubMed ID: 1609115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.